Advanced Search

 

Study ID Status Title Patient Level Data
RIT-I-000 Completed Phase I/II study of radiolabeled monoclonal antibody anti-B1 for the treatment of B-cell lymphomas.
RIT-II-001 Completed Multicenter, phase II dosimetry/validation study of 131 Iodine anti-B1 (murine) radioimmunotherapy for chemotherapy-refractory low-grade B-cell lymphomas and low-grade lymphomas that have transformed to higher grade histologies.
RIT-II-002 Completed A randomized study of Iodine-131 Anti-B1 Antibody versus Anti-B1 Antibody in chemotherapy-relapsed/refractory low-grade or transformed low-grade non-Hodgkin’s Lymphoma (NHL).
RIT-II-003 Completed Phase II trial of Iodine-131 Anti-B1 Antibody for previously untreated, advanced-stage, low-grade non-Hodgkin’s lymphoma
RM2006/00520/00 Completed A phase II multicenter, randomized, double-blind, placebo-controlled, dose-ranging, parallel group study of the safety and efficacy of a new chemical entity when administered orally in combination with ondansetron hydrochloride and dexamethasone for the prevention of chemotherapy-induced nausea ...
RO12003 Completed Efficacy and Safety of Rosiglitazone in the Treatment of Type 2 Diabetes Mellitus
ROF102100 Completed A randomised, double blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole (CR) (1-24 mg) administered once daily for 12 weeks in subjects with fibromyalgia Study Listed on ClinicalStudyDataRequest.com
ROP105323 Completed A Randomised, Double-Blind, Double-Dummy, Parallel Group Comparison of 24 Weeks of Treatment with Ropinirole Immediate Release Tablets (REQUIP IR) or Ropinirole Prolonged Release Tablets (SK&F-101468) in Advanced Stage Parkinson’s Disease Subjects who are not Adequately Controlled on L-dopa.
ROP105696 Completed A Post-Marketing Surveillance to monitor the safety of RequipTM (Ropinirole hydrochloride) administered in Korean subjects according to the prescribing information
ROP106064 Completed Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease - an Open-Label, Uncontrolled Study -
ROP109087 Completed An open label, repeat dose, dose escalation study conducted in Parkinson's Disease patients to characterize the pharmacokinetics and effect of food on ropinirole prolonged release (PR/CR) 12mg tablets. Study Listed on ClinicalStudyDataRequest.com
ROR104836 Completed A parallel group study to evaluate the efficacy and safety of ropinirole for 26 weeks and to further evaluate the incidence of augmentation and rebound for a further 40 weeks open-label extension treatment period in subjects suffering from moderate to severe Restless Legs Syndrome. Study Listed on ClinicalStudyDataRequest.com
ROR106470 Completed An open label, repeat dose, dose escalation study conducted in RLS patients to characterize pharmacokinetics and food effect of ropinirole controlled release for RLS
ROTA-Meta-Analysis-201212 Completed Integrated safety summary of GSK Biologicals’ HRV vaccine (Rotarix™)
ROTA-Meta-Analysis-201308 Completed Meta-analysis of risk of intussusception after the first and the second dose of Rotarix and Rotateq
ROX104805 Completed A 4-Week, Randomized, Double-Blind, Cohort Study to Evaluate the Safety and Tolerability of Converting from Ropinirole Immediate Release (IR) to Ropinirole Extended Release (XR) Formulation in Patients with Restless Legs Syndrome (RLS) Study Listed on ClinicalStudyDataRequest.com
RPS10001 Completed A phase I, monocentric, randomised, double-blind, double-dummy, cross-over study to compare the pharmacokinetics and the pharmacodynamic effects of Seretide 50 mg/250 mg bid after repeat dosing, delivered by Diskus™ versus RPID in patients with moderate asthma.
RPS30001/SFCF3002 Completed A Multicentre, Randomised, Double-Blind, Double-Dummy, Parallel-Group Study to establish Equivalence of the Fluticasone propionate/Salmeterol Combination (FSC) Product (100/50µg) via either the Reservoir Powder Inhalation Device (RPID) or via the Diskus* Inhaler over 12 Weeks in Children with Asthma
RPS30002/SFCF3001 Completed A Multicentre, Randomised, Double-Blind, Double-Dummy, Parallel-Group Study to Establish Equivalence of the Salmeterol/Fluticasone propionate Combination Product (50/250µg) via either the Reservoir Powder Inhalation Device (RPID) or via the Diskus™ Inhaler over 12 Weeks in Adolescents and Adults ...
RQ12003 Completed Treatment of Parkinson’s disease subjects which are on L-dopa with adjunct treatment with ropinirole (ReQuip) in neurology outpatient department.
RRL103628 Completed An Open-Label, Parallel-Group, Repeat-Dose Study to Investigate the Effects of End Stage Renal Disease and Haemodialysis on the Pharmacokinetics of Ropinirole (Study RRL103628) Study Listed on ClinicalStudyDataRequest.com
RRL103660 Completed A 12-Week, Multi-Center, Double-Blind, Placebo-Controlled, Parallel Group, Flexible Dose Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome (RLS) in RLS Patients with Sleep Disturbance and Periodic Limb Movements (PLM) During Sleep Study Listed on ClinicalStudyDataRequest.com
RRL106721 Completed A multicenter 3:1-randomized placebo-controlled double-blind Phase IIIb study on the effects of Ropinirole on mood/(subclinical) depression in the therapy of patients with moderate to severe idiopathic RLS in Germany
RXP110908 Completed Study RXP110908, a polysomnography study of GSK1838262 (XP13512) extended release tablets versus placebo in the treatment of Restless Legs Syndrome (RLS) and associated sleep disturbance
S2090309 Completed An Evaluation of a Low Dose Nicotine Lozenge in Relief of Provoked Acute Craving

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.